Skip to main content
. 2020 May 4;2020(5):CD012955. doi: 10.1002/14651858.CD012955.pub2

Comparison 15. Psychotherapy vs waiting list or no treatment.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
15.1 Primary: BPD symptom severity (continuous), at end of treatment 3 161 Std. Mean Difference (IV, Random, 95% CI) ‐0.49 [‐0.93, ‐0.05]
15.2 Primary: self‐harm (continuous), at end of treatment 2 128 Std. Mean Difference (IV, Random, 95% CI) ‐0.17 [‐0.52, 0.18]
15.3 Primary: suicide‐related outcomes (continuous), at end of treatment 2 108 Std. Mean Difference (IV, Random, 95% CI) ‐5.62 [‐16.39, 5.16]
15.4 Primary: psychosocial functioning (continuous) 5   Std. Mean Difference (IV, Random, 95% CI) Subtotals only
15.4.1 End of treatment 5 219 Std. Mean Difference (IV, Random, 95% CI) ‐0.56 [‐1.01, ‐0.11]
15.4.2 0‐6 months follow‐up 1 30 Std. Mean Difference (IV, Random, 95% CI) ‐0.89 [‐1.65, ‐0.13]
15.4.3 6‐12 months follow‐up 1 30 Std. Mean Difference (IV, Random, 95% CI) ‐1.04 [‐1.81, ‐0.27]
15.4.4 Above 12 months follow‐up 1 28 Std. Mean Difference (IV, Random, 95% CI) ‐0.38 [‐1.14, 0.37]
15.5 Secondary: anger (continuous), at end of treatment 2 128 Std. Mean Difference (IV, Random, 95% CI) ‐0.58 [‐1.70, 0.55]
15.6 Secondary: affective instability (continuous) 2   Std. Mean Difference (IV, Random, 95% CI) Subtotals only
15.6.1 End of treatment 2 128 Std. Mean Difference (IV, Random, 95% CI) ‐0.99 [‐1.36, ‐0.62]
15.6.2 0‐6 months follow‐up 1 30 Std. Mean Difference (IV, Random, 95% CI) ‐0.47 [‐1.20, 0.26]
15.6.3 6‐12 months follow‐up 1 30 Std. Mean Difference (IV, Random, 95% CI) ‐0.38 [‐1.10, 0.34]
15.6.4 Above 12 months follow‐up 1 30 Std. Mean Difference (IV, Random, 95% CI) ‐0.28 [‐1.01, 0.44]
15.7 Secondary: chronic feelings of emptiness (continuous), at end of treatment 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
15.8 Secondary: impulsivity (continuous) 3   Std. Mean Difference (IV, Random, 95% CI) Subtotals only
15.8.1 End of treatment 3 178 Std. Mean Difference (IV, Random, 95% CI) ‐0.52 [‐0.82, ‐0.22]
15.8.2 0‐6 months follow‐up 1 30 Std. Mean Difference (IV, Random, 95% CI) ‐0.90 [‐1.66, ‐0.14]
15.8.3 6‐12 months follow‐up 1 30 Std. Mean Difference (IV, Random, 95% CI) ‐0.79 [‐1.54, ‐0.04]
15.8.4 Above 12 months follow‐up 1 30 Std. Mean Difference (IV, Random, 95% CI) ‐0.75 [‐1.50, ‐0.01]
15.9 Secondary: interpersonal problems (continuous) 3   Std. Mean Difference (IV, Random, 95% CI) Subtotals only
15.9.1 End of treatment 3 120 Std. Mean Difference (IV, Random, 95% CI) ‐0.85 [‐1.23, ‐0.47]
15.9.2 0‐6 months follow‐up 1 30 Std. Mean Difference (IV, Random, 95% CI) ‐1.40 [‐2.21, ‐0.59]
15.9.3 6‐12 months follow‐up 1 30 Std. Mean Difference (IV, Random, 95% CI) ‐0.90 [‐1.66, ‐0.14]
15.9.4 Above 12 months follow‐up 1 30 Std. Mean Difference (IV, Random, 95% CI) ‐0.86 [‐1.62, ‐0.11]
15.10 Secondary: abandonment (continuous), at end of treatment 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
15.11 Secondary: identity disturbance (continuous), at end of treatment 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
15.12 Secondary: dissociation and psychotic‐like symptoms (continuous), at end of treatment 2 77 Std. Mean Difference (IV, Random, 95% CI) ‐0.13 [‐0.65, 0.39]
15.13 Secondary: depression (continuous), at end of treatment 6 239 Std. Mean Difference (IV, Random, 95% CI) ‐1.28 [‐2.21, ‐0.34]
15.14 Secondary: attrition (dichotomous), at end of treatment 3 144 Risk Ratio (M‐H, Random, 95% CI) 0.55 [0.20, 1.50]